Ingrid Rapp
Algemeen Directeur bij Labor Dr. Merk & Kollegen GmbH
Actieve functies van Ingrid Rapp
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Labor Dr. Merk & Kollegen GmbH
 Labor Dr. Merk & Kollegen GmbH BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Labor Dr. Merk & Kollegen GmbH is a German company that engages in research & development and manufacturing of vaccines and viral therapeutics. The company is based in Ochsenhausen, Germany. The CEO of the company is Ingrid Rapp. Labor Dr. Merk & Kollegen was acquired by Boehringer Ingelheim International GmbH on December 15, 2020. | Algemeen Directeur | - | - |
Loopbaan van Ingrid Rapp
Statistieken
Internationaal
| Duitsland | 2 |
Operationeel
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Labor Dr. Merk & Kollegen GmbH
Labor Dr. Merk & Kollegen GmbH BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Labor Dr. Merk & Kollegen GmbH is a German company that engages in research & development and manufacturing of vaccines and viral therapeutics. The company is based in Ochsenhausen, Germany. The CEO of the company is Ingrid Rapp. Labor Dr. Merk & Kollegen was acquired by Boehringer Ingelheim International GmbH on December 15, 2020. | Health Technology |
- Beurs
- Insiders
- Ingrid Rapp
- Ervaring
